Cell Genomics · 2024 · 23 citations · 55 references
MedicineCancer BiologyOncologyDrug DiscoveryMolecular OncologySignal TransductionCancer Cell SignalingCancer TranscriptomicsChemokine SignalingDrug-receptor InteractionsLigand BindingSignal Transduction In CancerCancer Signaling Network AnalysisCancer Signaling PathwaysG Protein-coupled Chemokine ReceptorsG Protein-coupled Receptor RegulationG Protein-coupled Receptor Signaling ComplexesInteraction Network StructureSurvival StratificationTumor Cell Survival Pathways
We explored the dysregulation of G-protein-coupled receptor (GPCR) ligand systems in cancer transcriptomics datasets to uncover new therapeutics opportunities in oncology. We derived an interaction network of receptors with ligands and their biosynthetic enzymes. Multiple GPCRs are differentially regulated together with their upstream partners across cancer subtypes and are associated to specific transcriptional programs and to patient survival patterns. The expression of both receptor-ligand (or enzymes) partners improved patient stratification, suggesting a synergistic role for the activation of GPCR networks in modulating cancer phenotypes. Remarkably, we identified many such axes across several cancer molecular subtypes, including many involving receptor-biosynthetic enzymes for neurotransmitters. We found that GPCRs from these actionable axes, including, e.g., muscarinic, adenosine, 5-hydroxytryptamine, and chemokine receptors, are the targets of multiple drugs displaying anti-growth effects in large-scale, cancer cell drug screens, which we further validated. We have made the results generated in this study freely available through a webapp (gpcrcanceraxes.bioinfolab.sns.it).
55
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin, Carrie Davis, Felix Schlesinger et al. · Bioinformatics · 2012 · 56.2K citations · Full text
Damian Szklarczyk, Annika L. Gable, David Lyon et al. · Nucleic Acids Research · 2018 · 19.2K citations · Full text